scPharmaceuticals to Announce First Quarter 2025 Financial Results After the Market Close on May 14, 2025
scPharmaceuticals (NASDAQ: SCPH), a pharmaceutical company focused on cardiorenal healthcare innovations, has scheduled its Q1 2025 financial results announcement for May 14, 2025, after market close. The company will host a conference call and audio webcast at 4:30 p.m. ET on the same day to discuss the quarterly results and provide a business update. Interested participants can access the call through a direct registration link, while the webcast and its replay will be available on the company's website under the Investor Relations section.
scPharmaceuticals (NASDAQ: SCPH), un'azienda farmaceutica specializzata in innovazioni per la salute cardiorenale, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per il 14 maggio 2025, dopo la chiusura del mercato. La società terrà una conference call e una webcast audio alle 16:30 ET dello stesso giorno per discutere i risultati trimestrali e fornire un aggiornamento sull'andamento aziendale. I partecipanti interessati possono accedere alla chiamata tramite un link di registrazione diretto, mentre la webcast e la sua registrazione saranno disponibili sul sito web della società nella sezione Relazioni con gli Investitori.
scPharmaceuticals (NASDAQ: SCPH), una compañía farmacéutica centrada en innovaciones para la salud cardiorrenal, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el 14 de mayo de 2025, después del cierre del mercado. La empresa realizará una llamada en conferencia y una transmisión de audio en línea a las 4:30 p.m. ET del mismo día para discutir los resultados trimestrales y ofrecer una actualización comercial. Los interesados pueden acceder a la llamada mediante un enlace de registro directo, mientras que la transmisión y su repetición estarán disponibles en el sitio web de la compañía en la sección de Relaciones con Inversores.
scPharmaceuticals (NASDAQ: SCPH)는 심장신장 건강 혁신에 주력하는 제약회사로, 2025년 1분기 재무 실적 발표를 2025년 5월 14일 시장 마감 후에 예정하고 있습니다. 회사는 같은 날 오후 4시 30분 ET에 분기 실적과 사업 현황 업데이트를 논의하기 위한 컨퍼런스 콜 및 오디오 웹캐스트를 진행할 예정입니다. 관심 있는 참가자는 직접 등록 링크를 통해 콜에 참여할 수 있으며, 웹캐스트와 재방송은 회사 웹사이트의 투자자 관계 섹션에서 확인할 수 있습니다.
scPharmaceuticals (NASDAQ : SCPH), une entreprise pharmaceutique spécialisée dans les innovations en santé cardiorénale, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le 14 mai 2025, après la clôture du marché. La société tiendra une conférence téléphonique et une webdiffusion audio à 16h30 ET le même jour afin de discuter des résultats trimestriels et de fournir une mise à jour commerciale. Les participants intéressés peuvent accéder à l'appel via un lien d'inscription direct, tandis que la webdiffusion et sa rediffusion seront disponibles sur le site internet de l'entreprise dans la section Relations Investisseurs.
scPharmaceuticals (NASDAQ: SCPH), ein Pharmaunternehmen, das sich auf Innovationen im Bereich der kardiorenalen Gesundheit spezialisiert hat, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für den 14. Mai 2025 nach Börsenschluss geplant. Das Unternehmen wird am selben Tag um 16:30 Uhr ET eine Telefonkonferenz und eine Audio-Webcast veranstalten, um die Quartalsergebnisse zu besprechen und ein Geschäftsupdate zu geben. Interessierte Teilnehmer können über einen direkten Registrierungslink an dem Anruf teilnehmen, während der Webcast und die Aufzeichnung auf der Unternehmenswebsite im Bereich Investor Relations verfügbar sein werden.
- None.
- None.
Management to host conference call and webcast, after-market on May 14, 2025, at 4:30 p.m. ET
BURLINGTON, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, May 14, 2025, to discuss the financial results for the first quarter 2025 and provide a business update.
Registration and access for the conference call can be completed through this direct registration link.
The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.
About scPharmaceuticals
At scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs.
Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.
Katherine Miranda
scPharmaceuticals Inc., (781) 301-6869
kmiranda@scpharma.com
Investors:
Matthew Beck
astr partners, (917) 415-1750
matthew.beck@astrpartners.com
FAQ
When will SCPH release its Q1 2025 earnings?
What time is scPharmaceuticals Q1 2025 earnings call?
How can I access SCPH's Q1 2025 earnings call?
Where can I find the replay of SCPH's Q1 2025 earnings webcast?
